Clincosm LogoSign in Get a demo

prostate cancer

Showing NaN - NaN of 185
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in London, Carlisle (TURP, UroLift)

Recruiting
  • Prostate Cancer
  • TURP
  • UroLift
  • London, Lon, United Kingdom
  • +2 more
Apr 24, 2023

Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +91 more
Jan 18, 2023

Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Birmingham, Alabama
  • +306 more
Jan 18, 2023

Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)

Completed
Has Results
  • Prostate Cancer
  • 70.2 Gy 3D-CRT/IMRT
  • 79.2 Gy 3D-CRT/IMRT
  • Long Beach, California
  • +85 more
Dec 27, 2022

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Prostate Cancer Trial in Canada (PSMA PET/CT guided intensification of therapy, Control Arm)

Recruiting
  • Prostate Cancer
  • PSMA PET/CT guided intensification of therapy
  • Control Arm
  • Kelowna, British Columbia, Canada
  • +13 more
Dec 14, 2022

Prostate Cancer Trial in United Kingdom (NeuroSAFE procedure, Standard RARP)

Active, not recruiting
  • Prostate Cancer
  • NeuroSAFE procedure
  • Standard RARP
  • Bristol, United Kingdom
  • +4 more
Dec 12, 2022

Prostate Cancer Trial in London (177Lu-PNT2002, High Dose Radiation)

Recruiting
  • Prostate Cancer
  • London, Ontario, Canada
    London Health Sciences Centre
Nov 22, 2022

Breast Cancer, Prostate Cancer, Quality of Life Trial in Worldwide (ASCAPE-based follow-up strategy)

Recruiting
  • Breast Cancer
  • +4 more
  • ASCAPE-based follow-up strategy
  • Athens, Greece
  • +4 more
Oct 28, 2022

Stratification in Early Prostate Cancer to Discriminate

Active, not recruiting
  • Prostate Cancer
  • NA (Observational)
  • London, United Kingdom
    University College Hospital
Oct 25, 2022

Prostate Cancer, Cardiovascular Disease Trial in Canada (Nutrition, Exercise, Smoking cessation)

Recruiting
  • Prostate Cancer
  • Cardiovascular Disease
  • Nutrition
  • +4 more
  • Waratah, New South Wales, Australia
  • +37 more
Oct 3, 2022

Prostate Cancer Trial in London (Nivolumab & Ipilimumab)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab & Ipilimumab
  • London, United Kingdom
    University College London Hospital
Sep 26, 2022

Prostate Cancer Trial (Active Surveillance)

Recruiting
  • Prostate Cancer
  • Active Surveillance
  • Bedford, United Kingdom
  • +4 more
Sep 22, 2022

Prostate Cancer Trial in Worldwide (MRI-guided Transurethral Ultrasound Ablation)

Recruiting
  • Prostate Cancer
  • MRI-guided Transurethral Ultrasound Ablation
  • Los Angeles, California
  • +14 more
Sep 12, 2022

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022

Prostate Cancer Trial in Worldwide (enzalutamide, abiraterone acetate, prednisone)

Recruiting
  • Prostate Cancer
  • Anchorage, Alaska
  • +126 more
Aug 23, 2022

Prostate Cancer Trial in Worldwide (Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +74 more
Aug 17, 2022

Prostate Cancer Trial in Worldwide (Standard of Care)

Recruiting
  • Prostate Cancer
  • Standard of Care
  • Birmingham, Alabama
  • +107 more
Aug 17, 2022

Prostate Cancer Trial in Worldwide (Abemaciclib, Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +116 more
Aug 17, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Radical Prostatectomy
  • TULSA Procedure
  • Tarzana, California
  • +7 more
Aug 10, 2022

Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)

Active, not recruiting
  • Melanoma
  • +9 more
  • MRx0518 Capsules
  • MRx0518/placebo Capsules
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Aug 10, 2022

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Prostate Cancer Trial in London (Luminal Index MRI (LI-MRI), LI-MRI targeted prostate biopsy, Plasma methylation signature

Recruiting
  • Prostate Cancer
  • Luminal Index MRI (LI-MRI)
  • +2 more
  • London, United Kingdom
    University College London Hospitals NHS Foundation Trust
Jul 28, 2022

Prostate Cancer Trial in London

Recruiting
  • Prostate Cancer
    • London, United Kingdom
      University College London
    Jul 28, 2022

    Prostate Cancer Trial in Worldwide (capivasertib, docetaxel, )

    Recruiting
    • Prostate Cancer
    • Phoenix, Arizona
    • +203 more
    Jul 27, 2022